Effect of restrictive versus liberal red cell transfusion strategies on haemostasis: systematic review and meta-analysis

Summary

Red cells play a key role in normal haemostasis in vitro but their importance clinically is less clear. The objective of this meta-analysis was to assess if correction of anaemia by transfusing red cells at a high haemoglobin threshold (liberal transfusion) is superior to transfusion at a lower haemoglobin threshold (restrictive transfusion) for reducing the risk of bleeding or thrombotic events. We searched for randomised controlled trials in any clinical setting that compared two red cell transfusion thresholds and investigated the risk of bleeding. We searched for studies published up to October 19, 2016 in The Cochrane Central Register of Controlled Trials, MEDLINE, PubMed, Embase, and the Transfusion Evidence Library and ISI Web of Science. Relative risks (RR) or Peto Odds Ratios (pOR) were pooled using a random-effect model. Nineteen randomised trials with 9852 participants were eligible for inclusion in this review. Overall there was no difference in the risk of any bleeding between transfusion strategies (RR 0.91, 95 % confidence interval [CI] 0.74 to 1.12). The risk of severe or life-threatening bleeding was lower with a restrictive strategy (RR 0.75, 95 % CI 0.57 to 0.99). There was no difference in the risk of thrombotic events (RR 0.83, 95 % CI 0.61 to 1.13). The risk of any bleeding was not reduced with liberal transfusion and there was no overall difference in the risk of thrombotic events. Data from the included trials do not support aiming for a high haemoglobin threshold to improve haemostasis. PROSPERO registration number CRD42016035519.

Supplementary Material to this article is available online at www.thrombosis-online.com.

Keywords

Haemorrhage - myocardial infarction - transfusion - stroke - venous thromboembolism

• References

• 1 Turitto VT, Weiss HJ. Red blood cells: their dual role in thrombus formation. Science 1980; 207: 541-543.
• 2 Chen H, Angerer JI, Napoleone M. et al. Hematocrit and flow rate regulate the adhesion of platelets to von Willebrand factor. Biomicrofluidics 2013; 07: 64113.
• 3 Walton BL, Byrnes JR, Wolberg AS. Fibrinogen, red blood cells, and factor XIII in venous thrombosis. J Thromb Haemost 2015; 13: S208-S215.
• 4 Whelihan MF, Zachary V, Orfeo T. et al. Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. Blood 2012; 120: 3837-3845.
• 5 Wohner N, Sótonyi P, Machovich R. et al. Lytic resistance of fibrin containing red blood cells. Arterioscler Thromb Vasc Biol 2011; 31: 2306-2613.
• 6 Horne 3rd MK, Cullinane AM, Merryman PK. et al. The effect of red blood cells on thrombin generation. Br J Haematol 2006; 133: 403-408.
• 7 Ho CH. Increase of red blood cells can shorten the bleeding time in patients with iron deficiency anemia. Blood 1998; 91: 1094.
• 8 Valeri CR, Khuri S, Ragno G. Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma-clotting proteins. Transfusion 2007; 47: 206S-248S.
• 9 Valeri CR, Cassidy G, Pivacek LE. et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 2001; 41: 977-983
• 10 Braekkan SK, Mathiesen EB, Njølstad I. et al. Hematocrit and risk of venous thromboembolism in a general population. The Tromso study. Haematologica 2010; 95: 270-275.
• 11 Silvain J, Abtan J, Kerneis M. et al. Impact of red blood cell transfusion on platelet aggregation and inflammatory response in anemic coronary and noncoronary patients: the TRANSFUSION-2 study (impact of transfusion of red blood cell on platelet activation and aggregation studied with flow cytometry use and light transmission aggregometry). J Am Coll Cardiol 2014; 63: 1289-1296.
• 12 Silvain J, Pena A, Cayla G. et al. Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study. Eur Heart J 2010; 31: 2816-2821.
• 13 Hearnshaw SA, Logan RF, Lowe D. et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 2011; 60: 1327-1335.
• 14 Mehta RH, Sheng S, O’Brien SM. et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes 2009; 02: 583-590.
• 15 Dubovoy T, Engoren M. Thrombotic Risks in Red Blood Cell Transfusions. Semin Thromb Hemost 2016; 42: 102-111.
• 16 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 06: e1000097.
• 17 Holst LB, Petersen MW, Haase N. et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. Br Med J 2015; 350: h1354.
• 18 Carson JL, Stanworth SJ, Roubinian N. et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2016; 10: CD002042.
• 19 Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011): The Cochrane Collaboration. 2011
• 20 Schünemann HJ, Oxman AD, Vist GE. et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S. eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration; 2011
• 21 Carson JL, Brooks MM, Abbott JD. et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013; 165: 964-971. e1
• 22 Carson JL, Terrin ML, Noveck H. et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-2462.
• 23 de Almeida JP, Vincent JL, Galas FR. et al. Transfusion requirements in surgical oncology patients: a prospective, randomized controlled trial. Anesthesiology 2015; 122: 29-38.
• 24 Fan YX, Liu FF, Jia M. et al. Comparison of restrictive and liberal transfusion strategy on postoperative delirium in aged patients following total hip replacement: a preliminary study. Arch Gerontol Geriatr 2014; 59: 181-185.
• 25 Foss NB, Kristensen MT, Jensen PS. et al. The effects of liberal versus restrictive transfusion thresholds on ambulation after hip fracture surgery. Transfusion 2009; 49: 227-234.
• 26 Grover M, Talwalkar S, Casbard A. et al. Silent myocardial ischaemia and haemoglobin concentration: a randomized controlled trial of transfusion strategy in lower limb arthroplasty. Vox Sang 2006; 90: 105-112.
• 27 Hébert PC, Wells G, Blajchman MA. et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417.
• 28 Holst LB, Haase N, Wetterslev J. et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014; 371: 1381-1391.
• 29 Jairath V, Kahan BC, Gray A. et al. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 2015; 386: 137-144.
• 30 Lacroix J, Hébert PC, Hutchison JS. et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007; 356: 1609-1619.
• 31 Lee JM, Chun HJ, Lee JS. Target level hemoglobin correction in patients with acute non-variceal upper gastrointestinal bleeding. Gastroenterology. 2014 146. Abstract S-321
• 32 Murphy GJ, Pike K, Rogers CA. et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015; 372: 997-1008.
• 33 Nielsen K, Johansson PI, Dahl B. et al. Perioperative transfusion threshold and ambulation after hip revision surgery--a randomized trial. BMC Anesthesiol 2014; 14: 89.
• 34 Robertson CS, Hannay HJ, Yamal JM. et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. J Am Med Assoc 2014; 312: 36-47.
• 35 Shehata N, Burns LA, Nathan H. et al. A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery. Transfusion 2012; 52: 91-99.
• 36 Villanueva C, Colomo A, Bosch A. et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 2013; 368: 11-21.
• 37 Walsh TS, Boyd JA, Watson D. et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit Care Med 2013; 41: 2354-2363.
• 38 Webert KE, Cook RJ, Couban S. et al. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion 2008; 48: 81-91.
• 39 Cholette JM, Swartz MF, Rubenstein J. et al. Outcomes Using a Conservative Versus Liberal Red Blood Cell Transfusion Strategy in Infants Requiring Cardiac Operation. Ann Thorac Surg 2017; 103: 206-214.
• 40 Blair SD, Janvrin SB, McCollum CN. et al. Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg 1986; 73: 783-785.
• 41 Garcia-Tsao G, Groszmann RJ, Fisher RL. et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 05: 419-424.
• 42 Carson JL, Carless PA, Hébert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012; 04: CD002042.
• 43 Docherty AB, O’Donnell R, Brunskill S. et al. Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis. Br Med J 2016; 352: i1351.